Reply to Kevin B. Ginsburg, Ava Zamani, and Tudor Borza’s Letter to the Editor re: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.06.012

IF 25.2 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2025-09-25 DOI:10.1016/j.eururo.2025.09.4130

Emmeli Palmstedt, Jonas Hugosson, Rebecka Arnsrud Godtman

引用次数: 0

Abstract

No Abstract

查看原文本刊更多论文

回复Kevin B. Ginsburg， Ava Zamani和Tudor Borza给编辑的信：Emmeli Palmstedt， Marianne ma nsson, Jonas Hugosson, rebecca Arnsrud Godtman。主动监测筛查发现的低危和中危前列腺癌：GÖTEBORG-1试验延长随访长达25年。Urol欧元。在出版社。https://doi.org/10.1016/j.eururo.2025.06.012

没有抽象的

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.